Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:30 am Sale |
2022-12-31 | 13G | Vyant Bio, Inc. VYNT |
FOD Capital LLC | 0 0.000% |
-294,987 (Position Closed) |
Filing History |
| 2022-02-14 1:04 pm Purchase |
2021-12-31 | 13G | Vyant Bio, Inc. VYNT |
FOD Capital LLC | 294,987 5.090% |
294,987 (New Position) |
Filing History |
| 2022-02-11 07:36 am Unchanged |
2021-12-31 | 13G | Vyant Bio, Inc. VYNT |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-10 6:25 pm Purchase |
2021-12-31 | 13G | Vyant Bio, Inc. VYNT |
Renaissance Technologies LLC | 19,268 0.330% |
19,268 (New Position) |
Filing History |
| 2022-02-09 5:05 pm Purchase |
2021-12-31 | 13G | Vyant Bio, Inc. VYNT |
Lind Global Macro Fund LP | 137,931 2.300% |
137,931 (New Position) |
Filing History |
| 2022-02-07 4:39 pm Purchase |
2021-12-31 | 13G | Vyant Bio, Inc. VYNT |
BIGGER CAPITAL FUND L P | 48,966 11.000% |
48,966 (New Position) |
Filing History |
| 2021-02-25 3:05 pm Unchanged |
2021-02-11 | 13D | CANCER GENETICS INC CGIX |
FiveT Investment Management Ltd | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-10 9:43 pm Purchase |
2020-12-31 | 13G | CANCER GENETICS INC CGIX |
Renaissance Technologies LLC | 242,801 5.940% |
74,769 (+44.50%) |
Filing History |
| 2021-02-10 9:26 pm Sale |
2020-12-31 | 13G | CANCER GENETICS INC CGIX |
Ionic Ventures LLC | 0 0.000% |
-250,000 (Position Closed) |
Filing History |
| 2021-02-09 06:17 am Purchase |
2021-02-01 | 13G | CANCER GENETICS INC CGIX |
Mitchell P. Kopin | 710,905 9.990% |
710,905 (New Position) |
Filing History |
| 2021-02-08 4:32 pm Purchase |
2021-01-28 | 13G | CANCER GENETICS INC CGIX |
BIGGER CAPITAL FUND L P | 689,656 9.700% |
689,656 (New Position) |
Filing History |
| 2021-02-03 4:46 pm Purchase |
2021-02-01 | 13G | CANCER GENETICS INC CGIX |
Lind Global Macro Fund LP | 710,656 9.900% |
710,656 (New Position) |
Filing History |
| 2021-01-14 3:44 pm Sale |
2020-12-31 | 13G | CANCER GENETICS INC CGIX |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 85 0.002% |
-227,187 (-99.96%) |
Filing History |
| 2020-11-09 10:39 am Purchase |
2020-10-29 | 13D | CANCER GENETICS INC CGIX |
FiveMore Fund Ltd | 155,542 3.820% |
155,542 (New Position) |
Filing History |
| 2020-11-02 06:02 am Purchase |
2020-11-02 | 13G | CANCER GENETICS INC CGIX |
Ionic Ventures LLC | 250,000 6.460% |
250,000 (New Position) |
Filing History |
| 2020-10-30 09:08 am Purchase |
2020-10-28 | 13G | CANCER GENETICS INC CGIX |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 227,272 5.870% |
227,272 (New Position) |
Filing History |